What You Should Know:
Notable, the leading automation platform for patient engagement and staff workflows, launched Notable Assistant, a first-of-its-kind patient assistant designed to expand access to healthcare information and services using large language models (LLMs) and conversational AI.Built on the rich data at the heart of the Notable platform, Patient AI, Notable Assistant introduces an accessible experience, in which every patient has a personal guide navigating them through
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Bold Secures $17M to Expand Healthy Aging Platform with Medicare Plans
What You Should Know:
Bold, a Los Angeles-based healthy aging platform raises $17M in Series A funding led by Rethink Impact, with participation from Samsung Next and existing investors Andreessen Horowitz (a16z) Bio + Health, Khosla Ventures, GingerBread Capital, and Primetime Partners. The latest funding, bringing its total amount raised to $27M. The company plans to utilize the capital to support Bold's continued expansion with national and regional Medicare plans and provider
Read More
Adventist Health Taps Luna to Improve In-Home Physical Therapy Access Across LA
What You Should Know:
Luna, the leading provider of in-home, in-person physical therapy, and Adventist Health Simi Valley, a nonprofit, integrated health system serving more than 80 communities on the West Coast, have today announced a partnership to improve access to in-home, in-person outpatient physical therapy across the greater Los Angeles area.Luna will provide Adventist Health with a seamless, coordinated solution for patients that improve access to outpatient physical therapy,
Read More
Report: The State of the Healthcare Employee Experience 2023
What You Should Know:
- Nurses with managers who support their development are 10.6X more likely to stay in their job, according to a new study by Perceptyx, the employee listening and manager effectiveness platform.Nurses who have opportunities for learning in their roles (e.g. upskilling) are 7.3X more likely (and those who have greater career opportunities are 6.2X more likely) to stay with their organizations in the near term.
- The report, State of the Healthcare
Read More
Personalized Patient Engagement Can Help Cure America’s Non-Adherence Problem
Today, more than 131 million Americans – 66 percent of all adults in the U.S. – use prescription drugs, and one in four use three or more, according to the Health Policy Institute. Not only are we being prescribed more drugs than ever before, but we’re paying more for them too: the U.S. has the highest per-capita pharmaceutical spending among the developed countries. In 2021, the U.S. healthcare system spent $603 billion on prescription drugs.
But even as we’re being prescribed more drugs,
Read More
Half of Doctors/Nurses Eager to Adopt Generative AI Tools
What You Should Know:
Elsevier Health, a global leader in information and data analytics, released its Clinician of the Future 2023 report, which serves as the global health ecosystem’s most recent pulse on what doctors and nurses think about the changes and challenges in healthcare, including the rapid rise of generative AI products and platforms.The report finds that almost half of all doctors and nurses are eager for physicians to utilize this innovative technology in the future to
Read More
Researchers Develop DNA Biosensor for Early Cervical Cancer Diagnosis
What You Should Know:
Recently, researchers from Chung-Ang University developed an electrochemical DNA biosensor with enhanced sensitivity for effective HPV detection with high specificity.They achieved this feat using a graphitic nano-onion/molybdenum disulfide nanosheet composite with improved conductive electron transfer compared to the nanosheet alone. Their breakthrough can open doors to the development of electrochemical biosensors for early diagnosis of various ailments.
Effective
Read More
Ibex Launches Breast Cancer Biomarker Diagnostic Platform
What You Should Know:
Ibex Medical Analytics launches Galen Breast HER2™, a novel breast cancer AI-powered biomarker scoring solution developed in collaboration with AstraZeneca and Daiichi Sankyo, to support improved patient outcomes.Galen Breast HER2 is an AI-powered biomarker scoring solution to aid pathologists with reproductible HER2 assessment for breast cancer. The platform allows clinicians to rapidly and accurately identify patients with HER2-low who would benefit from
Read More
Philips Reaches US Economic Loss Resolution for Respiratory Device Recall
What You Should Know:
- Philips Respironics, has reached an agreement to resolve all economic loss claims in the US Multidistrict Litigation (MDL) related to Philips Respironics’ voluntary recall of certain sleep and respiratory care devices.
- The agreement will provide predefined cash awards to all eligible participants in the US depending on the type of device, extended warranties on all replacement devices, and an additional cash award if they return the recalled device
Read More
OM1 Launches Parkinson’s Disease Real-World Datasets for Neuroscience
What You Should Know:
Today, OM1 announced the launch of its Parkinson’s Disease datasets, enhancing its Mental Health & Neuroscience Real-World Data Network.OM1’s Mental Health & Neuroscience Real-World Data Network, which already includes robust datasets focused on Major Depressive Disorder, Multiple Sclerosis, Bipolar Disorder I and Schizophrenia, will further expand to include Alzheimer’s Disease in the coming months.
Parkinson’s Disease Premium Dataset
Nearly
Read More
